Immunological changes in depression

抑郁症的免疫学变化

阅读:9
作者:Sunil Goyal, Kalpana Srivastava, Chaitanya Kodange, Pookala Shivram Bhat

Background

The role of Immune system in the pathophysiology of depressive disorders is a field of active research, however Indian literature is sparse. The present study was planned to assess the immunological response in depression. Materials and

Conclusion

Dysregulation of immune response occurs in depressed patients with changes in both cell mediated and humoral immunity. Further, antidepressant treatment affects the immune status of depressed patients.

Methods

The study comprised of 100 subjects. There were fifty cases of depression satisfying the ICD-10 criteria with no physical illness and HIV negative status and fifty age and sex matched healthy volunteers. Depression was assessed on HRSD and BDI scales. Assessment of three markers each of cellular immunity (NK cells, CD4, CD8 cells) and humoral immunity (Il-2, IL-6 and CRP) was carried out on both groups and depressed patients were reassessed on all parameters after 08 weeks of treatment with antidepressants (SSRIs or TCAs).

Results

NK Cells were significantly higher in the depressed group and CD 8 Cells and CD 4 Cells were higher in the control group (P = 0.001). Depressed group before treatment v/s control group differed significantly in the cell mediated immune markers. IL-2 levels were higher in the control group. The markers of cell mediated immunity i.e., NK cells, CD4, CD8 had increased significantly after treatment (P =< 0.001). The humoral immunity markers (CRP and IL-2) decreased significantly after treatment (P =< 0.001). However IL -6 levels were raised significantly in the subjects after treatment (P =< 0.001).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。